Ami B Bhatt1, Peter H Stone. 1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract
PURPOSE OF REVIEW: Angina pectoris affects at least 6.6 million people in the US and approximately 400,000 new cases of stable angina occur each year. Angina may be one of the first signs of ischemic heart disease, although it is likely not causally related to the likelihood of plaque rupture leading to an acute coronary syndrome. Modalities for treatment of angina should be used maximally to improve quality of life and decrease cardiovascular morbidity and mortality. The current recommended pharmacologic and invasive approaches, as well as novel therapies, are reviewed. RECENT FINDINGS: Antiischemic agents, including beta-blockers, nitrates and calcium channel blockers, remain the mainstay in the prevention of angina. Revascularization via percutaneous interventions or coronary bypass surgery are appropriate in specific cases or when medical treatment fails. Noninvasive treatment options for refractory angina, metabolic agents, and vasodilator therapies are adding to the armamentarium to prevent and treat angina. SUMMARY: A multifaceted approach is optimal to address the prevention of angina. Once angina is recognized, there are many modalities that lessen the incidence of daily life-induced and exercise-induced angina and ischemia. Angina management is best addressed by pharmacologic and lifestyle interventions.
PURPOSE OF REVIEW: Angina pectoris affects at least 6.6 million people in the US and approximately 400,000 new cases of stable angina occur each year. Angina may be one of the first signs of ischemic heart disease, although it is likely not causally related to the likelihood of plaque rupture leading to an acute coronary syndrome. Modalities for treatment of angina should be used maximally to improve quality of life and decrease cardiovascular morbidity and mortality. The current recommended pharmacologic and invasive approaches, as well as novel therapies, are reviewed. RECENT FINDINGS: Antiischemic agents, including beta-blockers, nitrates and calcium channel blockers, remain the mainstay in the prevention of angina. Revascularization via percutaneous interventions or coronary bypass surgery are appropriate in specific cases or when medical treatment fails. Noninvasive treatment options for refractory angina, metabolic agents, and vasodilator therapies are adding to the armamentarium to prevent and treat angina. SUMMARY: A multifaceted approach is optimal to address the prevention of angina. Once angina is recognized, there are many modalities that lessen the incidence of daily life-induced and exercise-induced angina and ischemia. Angina management is best addressed by pharmacologic and lifestyle interventions.
Authors: Michael McGillion; Philippe L L'Allier; Heather Arthur; Judy Watt-Watson; Nelson Svorkdal; Tammy Cosman; Paul Taenzer; Anil Nigam; Louise Malysh Journal: Can J Cardiol Date: 2009-07 Impact factor: 5.223
Authors: Michael McGillion; Allison Cook; J Charles Victor; Sandra Carroll; Julie Weston; Kevin Teoh; Heather M Arthur Journal: Vasc Health Risk Manag Date: 2010-09-07
Authors: Clarissa G Rodrigues; Rodrigo D M Plentz; Thiago Dipp; Felipe B Salles; Imarilde I Giusti; Roberto T Sant'Anna; Bruna Eibel; Ivo A Nesralla; Melissa Markoski; Nance N Beyer; Renato A K Kalil Journal: Arq Bras Cardiol Date: 2013-07-09 Impact factor: 2.000
Authors: Michael Hugh McGillion; Sandra Lee Carroll; Kelly Metcalfe; Heather Mary Arthur; Joseph Charles Victor; Robert McKelvie; Etienne Marc Jolicoeur; Marie-Gabrielle Lessard; James Stone; Nelson Svorkdal; John George Hanlon; Ada Andrade; Joel Niznick; Louise Malysh; William McDonald; Bonnie Stevens; Peter Coyte; Dawn Stacey Journal: Health Qual Life Outcomes Date: 2014-06-11 Impact factor: 3.186